Skip to main content
Top
Published in: BMC Infectious Diseases 1/2018

Open Access 01-12-2018 | Research article

Hospitalization rates and outcome of invasive bacterial vaccine-preventable diseases in Tuscany: a historical cohort study of the 2000–2016 period

Authors: Elena Chiappini, Federica Inturrisi, Elisa Orlandini, Maurizio de Martino, Chiara de Waure

Published in: BMC Infectious Diseases | Issue 1/2018

Login to get access

Abstract

Background

Invasive bacterial diseases (IBD) are a serious cause of hospitalization, sequelae and mortality. Albeit a low incidence, an increase in cases due to H. influenzae was registered in the past 4 years and, in the Tuscany region, an excess of cases due to N. meningitidis since 2015 is alarming. The purpose of this study is to deepen the knowledge of IBD epidemiology in Tuscany with particular attention to temporal trends.

Methods

Tuscan residents hospitalized for IBD from January 1st 2000 to March 18th 2016 were selected from the regional hospital discharge database based on ICD-9-CM codes. Age-specific and standardized hospitalization rates were calculated together with case-fatality rates (CFRs). A time-trend analysis was performed; whereas, prognostic factors of death were investigated through univariable and multivariable analyses.

Results

The average standardized hospitalization rates for invasive meningococcal diseases (IMD), invasive pneumococcal diseases and invasive diseases due to H. influenzae from 2000 to 2016 were 0.6, 1.8, and 0.2 per 100,000, respectively. The average CFRs were 10.5%, 14.5% and 11.5% respectively with higher values in the elderly. Older age was significantly associated with higher risk of death from all IBD. A significant reduction in hospitalization rates for IMD was observed after meningococcal C conjugate vaccine introduction. The Annual Percentage Change (APC) was -13.5 (95% confidence interval (CI) -22.3; -3.5) in 2005–2013 but has risen since that period. Furthermore, a significant increasing trend of invasive diseases due to H. influenzae was observed from 2005 onwards in children 1–4 years old (APC 13.3; 95% CI 0; 28.3).

Conclusions

This study confirms changes in the epidemiology of invasive diseases due to H. influenzae and IMD. Furthermore, attention is called to the prevention of IBD in the elderly because of the age group’s significantly higher rate of hospitalizations and deaths for all types of IBD.
Appendix
Available only for authorised users
Literature
6.
go back to reference Center for Disease Control and Prevention (CDC), World Health Organization (WHO). Epidemiology of Meningitis Caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae. Lab. Methods Diagnosis Meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus Influ. 2nd ed., 2011. Center for Disease Control and Prevention (CDC), World Health Organization (WHO). Epidemiology of Meningitis Caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae. Lab. Methods Diagnosis Meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus Influ. 2nd ed., 2011.
11.
go back to reference Center for Disease Control and Prevention (CDC). Haemophilus influenzae. In: Hamborsky J, Kroger A, Wolfe S, editors. Epidemiology and Prevention of Vaccine-Preventable Diseases. 13th ed., Washington D.C.: Public Health Foundation; 2015. Center for Disease Control and Prevention (CDC). Haemophilus influenzae. In: Hamborsky J, Kroger A, Wolfe S, editors. Epidemiology and Prevention of Vaccine-Preventable Diseases. 13th ed., Washington D.C.: Public Health Foundation; 2015.
12.
go back to reference Center for Disease Control and Prevention (CDC). Pneumococcal Disease. In: Hamborsky J, Kroger A, Wolfe S, editors. Epidemiology and Prevention of Vaccine-Preventable Diseases. 13th ed., Washington D.C.: Public Health Foundation; 2015. Center for Disease Control and Prevention (CDC). Pneumococcal Disease. In: Hamborsky J, Kroger A, Wolfe S, editors. Epidemiology and Prevention of Vaccine-Preventable Diseases. 13th ed., Washington D.C.: Public Health Foundation; 2015.
13.
17.
go back to reference Baldo V, Cocchio S, Gallo T, Furlan P, Clagnan E, Del Zotto S, et al. Impact of pneumococcal conjugate vaccination: a retrospective study of hospitalization for pneumonia in north-East Italy. J Prev Med Hyg. 2016;57:E61–8.PubMedPubMedCentral Baldo V, Cocchio S, Gallo T, Furlan P, Clagnan E, Del Zotto S, et al. Impact of pneumococcal conjugate vaccination: a retrospective study of hospitalization for pneumonia in north-East Italy. J Prev Med Hyg. 2016;57:E61–8.PubMedPubMedCentral
20.
go back to reference Trotter C, Samuelsson S, Perrocheau A, de Greeff S, de Melker H, Heuberger S, et al. Ascertainment of meningococcal disease in Europe. Euro Surveill. 2005;10:247–50.CrossRefPubMed Trotter C, Samuelsson S, Perrocheau A, de Greeff S, de Melker H, Heuberger S, et al. Ascertainment of meningococcal disease in Europe. Euro Surveill. 2005;10:247–50.CrossRefPubMed
22.
go back to reference National Center of Epidemiology and Surveillance and Health Promotion (CNESPS), National Institute for Health (Istituto Superiore di Sanità ISS). Data and evidences for the use of anti-pneumococcal vaccines in risk subjects of all ages and for the eventual vaccination of the elder population. Rome: 2013. National Center of Epidemiology and Surveillance and Health Promotion (CNESPS), National Institute for Health (Istituto Superiore di Sanità ISS). Data and evidences for the use of anti-pneumococcal vaccines in risk subjects of all ages and for the eventual vaccination of the elder population. Rome: 2013.
23.
go back to reference Italian Ministry of Health, National Institute for Health (Istituto Superiore di Sanità ISS). Italian Vaccine Action Plan 2016-2018. 2015. Italian Ministry of Health, National Institute for Health (Istituto Superiore di Sanità ISS). Italian Vaccine Action Plan 2016-2018. 2015.
24.
go back to reference Gasparini R, Amicizia D, Lai PL, Panatto D. Meningococcal B vaccination strategies and their practical application in Italy. J Prev Med Hyg. 2015;56:e133–E139.PubMedPubMedCentral Gasparini R, Amicizia D, Lai PL, Panatto D. Meningococcal B vaccination strategies and their practical application in Italy. J Prev Med Hyg. 2015;56:e133–E139.PubMedPubMedCentral
26.
go back to reference National Institute for Health (Istituto Superiore di Sanità ISS). Surveillance data on invasive bacterial diseases updated to April 4th 2016. Rome: 2016. National Institute for Health (Istituto Superiore di Sanità ISS). Surveillance data on invasive bacterial diseases updated to April 4th 2016. Rome: 2016.
29.
go back to reference Italian Ministry of Health. Circolare n. 5783 del 1° marzo 2016. 2016. Italian Ministry of Health. Circolare n. 5783 del 1° marzo 2016. 2016.
30.
go back to reference Italian Ministry of Health. Decreto Ministeriale 28 Dicembre 1991. Istituzione della scheda di dimissione ospedaliera. 1992 G.U. 17 gennaio, n.13. Italian Ministry of Health. Decreto Ministeriale 28 Dicembre 1991. Istituzione della scheda di dimissione ospedaliera. 1992 G.U. 17 gennaio, n.13.
33.
go back to reference National Institute for Health (Istituto Superiore di Sanità ISS). ICONA 2003: National infant vaccination coverage in Italy. Rapporti ISTISAN 03/37 2003. National Institute for Health (Istituto Superiore di Sanità ISS). ICONA 2003: National infant vaccination coverage in Italy. Rapporti ISTISAN 03/37 2003.
34.
go back to reference National Institute for Health (Istituto Superiore di Sanità ISS). ICONA 2008: National vaccination coverage survey among children and adolescents. Rapporti ISTISAN 09/29 2009. National Institute for Health (Istituto Superiore di Sanità ISS). ICONA 2008: National vaccination coverage survey among children and adolescents. Rapporti ISTISAN 09/29 2009.
35.
go back to reference Armitage P, Berry G, Matthews J. Statistical methods in medical research. 3rd ed. Oxford: Blackwell Scientific Publications; 1994. Armitage P, Berry G, Matthews J. Statistical methods in medical research. 3rd ed. Oxford: Blackwell Scientific Publications; 1994.
36.
go back to reference Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19:335–51.CrossRefPubMed Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19:335–51.CrossRefPubMed
37.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.CrossRefPubMed Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.CrossRefPubMed
38.
go back to reference Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi J-C, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130–9.CrossRefPubMed Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi J-C, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130–9.CrossRefPubMed
42.
go back to reference Heymann D, Aylward B. Mass vaccination in public health. Control Commun. Dis. Man. 19th ed., Washington D.C.: American Public Health Association; 2008. Heymann D, Aylward B. Mass vaccination in public health. Control Commun. Dis. Man. 19th ed., Washington D.C.: American Public Health Association; 2008.
46.
go back to reference Germinario C, Tafuri S, Vece MM, Prato R. Pneumococcal polysaccharide immunization strategies in Italian regions. Ig Sanita Pubbl. 2010;66:659–70.PubMed Germinario C, Tafuri S, Vece MM, Prato R. Pneumococcal polysaccharide immunization strategies in Italian regions. Ig Sanita Pubbl. 2010;66:659–70.PubMed
48.
go back to reference Ludwig E, Bonanni P, Rohde G, Sayiner A, Torres A. The remaining challenges of pneumococcal disease in adults. Eur Respir Rev. 2012;21. Ludwig E, Bonanni P, Rohde G, Sayiner A, Torres A. The remaining challenges of pneumococcal disease in adults. Eur Respir Rev. 2012;21.
49.
go back to reference Gibson GJ, Loddenkemper R, Lundbäck B, Sibille Y. Respiratory health and disease in Europe: the new European lung white book. Eur Respir J. 2013;42. Gibson GJ, Loddenkemper R, Lundbäck B, Sibille Y. Respiratory health and disease in Europe: the new European lung white book. Eur Respir J. 2013;42.
50.
go back to reference Daly E, Mason A, Goldacre M. Using case fatality rates as a health outcome indicator: literature review | National Centre for health outcomes development (NCHOD). 2000. Daly E, Mason A, Goldacre M. Using case fatality rates as a health outcome indicator: literature review | National Centre for health outcomes development (NCHOD). 2000.
Metadata
Title
Hospitalization rates and outcome of invasive bacterial vaccine-preventable diseases in Tuscany: a historical cohort study of the 2000–2016 period
Authors
Elena Chiappini
Federica Inturrisi
Elisa Orlandini
Maurizio de Martino
Chiara de Waure
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2018
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-018-3316-1

Other articles of this Issue 1/2018

BMC Infectious Diseases 1/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.